Sujata M Bhavnani (S M Bhavnani)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Escherichia Coli

Urinary Tract Infection

Multidrug Resistant

Extracorporeal Membrane Oxygenation

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Kathryn Liolios, Michael Trang, Christopher M Rubino, Judith N Steenbergen, Lawrence Friedrich, Evan Tzanis, Paul G Ambrose
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections. Antimicrobial agents and chemotherapy (2024)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
H Ganesan, Vipul K Gupta, M C Safir, Sujata M Bhavnani, A K Talley, David Melnick, Christopher M Rubino
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide. Antimicrobial agents and chemotherapy (2023)
A J Lepak, Michael Trang, J P Hammel, Helio Silva Sader, Sujata M Bhavnani, Brian D VanScoy, J M Pogue, Paul G Ambrose, David R Andes, null null
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial agents and chemotherapy (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Michael Trang, Justin C Bader, Catharine C Bulik, Brian D VanScoy, Christopher M Rubino, Michael D Huband, Lawrence Friedrich, Judith N Steenbergen, Paul G Ambrose
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial agents and chemotherapy (2023)
Michael Trang, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics. Antimicrobial agents and chemotherapy (2023)
Sujata M Bhavnani, Michael Trang, David C Griffith, Olga Lomovskaya, J P Hammel, J S Loutit, S K Cammarata, M N Dudley, Paul G Ambrose, Christopher M Rubino
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Antimicrobial agents and chemotherapy (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, Steven Fikes, Sujata M Bhavnani, Philippa B Elefante, Nicole E Scangarella-Oman, Paul G Ambrose
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems. Antimicrobial agents and chemotherapy 65 (12) (2021)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, M Courtney Safir, Brian D VanScoy, Yu Nagira, Christopher M Rubino, Nobuo Sato, Tomokazu Koresawa, Kenichiro Kondo, Paul G Ambrose
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution. Antimicrobial agents and chemotherapy 64 (10) (2020)
Brian D VanScoy, Nicole E Scangarella-Oman, Steven Fikes, Sharon Min, Jianzhong Huang, Karen Ingraham, Sujata M Bhavnani, Haley Conde, Paul G Ambrose
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 64 (10) (2020)